$22.74
1.245.77%
Last update: Nov 9, 4:00 PM

The average analyst price target for Tango Therapeutics is $37, 62.7% above the current price. Of 14 analysts, 13 rate it Buy and 1 Hold. Targets range from $12 to $69. The latest change came on Oct 16, 2026, when William Blair initiated coverage of Tango Therapeutics with an Outperform rating.
Price Target Range — 12 Quarters
Analyst Consensus — 14 Analysts
Rating Trend — Last 9 Months